IP Library Granted Patent US 9,241,902
Granted Patent B2
US 9,241,902 · App. 10/739,451 · Granted Jan 26, 2016

Chewable soft capsules containing ungelatinized starch

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,241,902
App. No.
10/739,451
Granted
Jan 26, 2016
Kind
B2
Abstract

A soft chewable capsule film suitable for medicament or foodstuff encapsulation, and a method of fabricating capsules from such a film. Such capsules demonstrate fast rupture in the oral cavity, good mouth feel and chewability, and rapid dissolution of the shell components. In particular, the modified starch is substantially ungelatinized, due at least in part to the processing temperature, and may act as a water retention agent to promote hydration. Additionally, gelatins are selected for bloom strengths that result in a robust capsules that may be fabricated at a thinner wall thickness than previously experienced in the art. Accordingly, such thin capsules have a smaller mass than traditional capsules of the same size and dissolve more quickly than chewable capsules having greater thicknesses. The capsules may be fabricated by a rotary die process at speeds greater than those generally known for soft chewable capsules.

Claims (21)

1. A finished soft gelatin capsule ready for packaging, comprising a capsule shell formed from a capsule film having a thickness not exceeding about 0.025 inches,

wherein the capsule shell has an end composition comprising:

at least one gelatin of about 275 bloom in about 20-55 weight % gelatin;

plasticizer in about 19-40 weight %; and

at least one hydroxypropylated starch in about 5-35 weight %, wherein the at least one hydroxypropylated starch is near, or in excess of, 50% ungelatinized; and

a water content of 9.5-11.5 weight %, wherein the capsule shell is processed at a temperature no greater than 65° C.,

wherein the finished soft gelatin capsule is edible and chewable, and

wherein the finished soft gelatin capsule ruptures in an oral cavity.

2. The capsule of claim 1 , wherein the plasticizer comprises at least glycerin.

3. The capsule of claim 1 , wherein the plasticizer comprises at least sorbitol.

4. The capsule of claim 1 , wherein the plasticizer is selected from the group consisting of polyethylene glycol, sucrose, mannitol, corn syrup, fructose, cellulose, dioctyl-sodium sulfosuccinate, triethyl citrate, tributyl citrate, 1,2-propylenglycol, mono-, di-or triacetates of glycerol, and natural gum.

5. The capsule of claim 1 , wherein the at least one gelatin comprises about 25-40 weight % of the capsule.

6. The capsule of claim 1 , wherein the at least one hydroxypropylated starch comprises 7-30 weight % of the capsule.

7. The capsule of claim 1 , wherein the at least one gelatin is a bovine gelatin.

8. The capsule of claim 1 , wherein the at least one gelatin is a combination of fish and bovine gelatins.

9. The capsule of claim 8 , wherein fish gelatin comprises about 5-95 weight % and bovine gelatin comprises about 5-95 weight % of the capsule.

10. The capsule of claim 8 , wherein the combination of gelatins comprises about 25-35 weight % fish gelatin and about 65-75 weight % bovine gelatin.

11. The capsule of claim 8 , wherein fish gelatin comprises about 28 weight % and bovine gelatin comprises about 72 weight %.

12. The capsule of claim 1 , wherein the at least one gelatin is a combination of a plurality of fish gelatins.

13. The capsule film of claim 1 , wherein the capsule is formed from a capsule film having a thickness less than about 0.020 inches.

14. The capsule film of claim 1 , wherein the capsule is formed from a capsule film having a thickness less than about 0.015 inches.

Assignments (6)
RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL (019323/0302) Recorded Dec 19, 2024
From: JPMORGAN CHASE BANK, N.A.
To: CATALENT PHARMA SOLUTIONS, LLC; R.P. SCHERER TECHNOLOGIES, INC.; R.P. SCHERER TECHNOLOGIES, LLC; R.P. SCHERER CORPORATION
Reel/Frame 069750/0933 →
SECURITY INTEREST Recorded Dec 19, 2024
From: CATALENT CTS (KANSAS CITY), LLC; REDWOOD BIOSCIENCE, INC.; R.P. SCHERER TECHNOLOGIES, LLC; CATALENT WELLNESS, LLC; CATALENT PHARMA SOLUTIONS, INC.; CATALENT WELLNESS NEW JERSEY, LLC; CATALENT MARYLAND, INC.; CATALENT GREENVILLE, INC.; CATALENT MICRON TECHNOLOGIES, INC.; CATALENT SAN DIEGO, INC.; CATALENT WELLNESS VIRGINIA, LLC; CATALENT USA PACKAGING, LLC; CATALENT PHARMA SOLUTIONS, LLC
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 069743/0458 →
NOTICE OF SUCCESSION OF AGENCY Recorded May 17, 2019
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 049217/0981 →
CHANGE OF NAME Recorded Jul 24, 2007
From: CARDINAL HEALTH 400, INC.; CARDINAL HEALTH 406, LLC; CARDINAL HEALTH 409, INC.; CARDINAL HEALTH 421, INC.; CARDINAL HEALTH PTS, LLC
To: CATALENT USA WOODSTOCK, INC.; CATALENT USA PACKAGING, LLC; CATALENT PHARMA SOLUTIONS, INC.; CATALENT USA PAINTBALL, INC.; CATALENT PHARMA SOLUTIONS, LLC
Reel/Frame 019588/0622 →
SECURITY AGREEMENT Recorded May 22, 2007
From: PTS ACQUISITION CORP.; PTS INTERMEDIATE HOLDINGS LLC; CARDINAL HEALTH 400, INC.; CARDINAL HEALTH 406, LLC; CARDINAL HEALTH 421, INC.; CARDINAL HEALTH PTS, LLC; R.P. SCHERER TECHNOLOGIES, INC.; GLACIER CORPORATION; CARDINAL HEALTH 409, INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 019323/0302 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2006
From: ROWE, DENNIS; GARNETT, KELVIN
To: R.P. SCHERER TECHNOLOGIES, INC.
Reel/Frame 017777/0359 →